Zogenix (ZGNX) News Today → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free ZGNX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative March 23, 2024 | morningstar.comHwasung Industrial Co Ltd 002460July 6, 2023 | fool.comAlcon (NYSE: ALC)May 21, 2023 | morningstar.comLongeveron Inc Ordinary Shares - Class AOctober 11, 2022 | businesswire.comHow Women Lead #GetonBoard Week Honorees Are Helping Catapult Fearless Women Leaders into Board Seats - Business WireSeptember 30, 2022 | forbes.comBiocryst PharmaceuticalsSeptember 26, 2022 | marketscreener.comNippon Shinyaku : Fintepla® (fenfluramine) Approved in Japan for the Treatment of Seizures Associated with Dravet syndrome - Marketscreener.comSeptember 13, 2022 | marketscreener.comPROMIS NEUROSCIENCES INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.comSeptember 10, 2022 | bizjournals.comHow Women Lead appoints three new executive board members - Bizwomen - The Business JournalsSeptember 9, 2022 | bizjournals.comEast Bay Biotech Companies - San Francisco Business Times - The Business JournalsSeptember 9, 2022 | prnewswire.comOncolytics Biotech® Appoints Jonathan Rigby to its Board of Directors - PR NewswireSeptember 8, 2022 | streetinsider.comOncolytics Biotech® Appoints Jonathan Rigby to its Board of Directors - StreetInsider.comSeptember 7, 2022 | finance.yahoo.comOncolytics Biotech® Appoints Jonathan Rigby to its Board of Directors - Yahoo FinanceAugust 30, 2022 | bizjournals.comWith early-cancer detection technology, Delfi Diagnostics looks to beat out Guardant Health, Illumina's Grail and others - San Francisco Business Times - The Business JournalsAugust 29, 2022 | thestreet.comDepomed Reports Dip in Earnings, Reduces Revenue GuidanceAugust 23, 2022 | prnewswire.comDelfi Diagnostics Adds Finance and Market Access Leadership as It Prepares for Commercial Launch - PR NewswireAugust 16, 2022 | businesswire.comNuvig Therapeutics Expands Leadership Team with the Appointment of Dr. Joanne Quan as Chief Medical Officer - Business WireAugust 15, 2022 | streetinsider.comNuvig Therapeutics Expands Leadership Team with the Appointment of Dr. Joanne Quan as Chief Medical Officer - StreetInsider.comAugust 9, 2022 | businesswire.comDravet Syndrome Treatment Market Report 2022-2029: Stiripentol and Cannabidiol to Contribute to Significant Growth of 11.7% - ResearchAndMarkets.com - Business WireAugust 3, 2022 | streetinsider.comTevard Biosciences Appoints Zoya Ignatova to Its Scientific Advisory Board - StreetInsider.comAugust 2, 2022 | prnewswire.comGeno Hires First Chief Legal Officer on Path to Accelerate the Transition to More Sustainable Materials - PR NewswireJuly 28, 2022 | marketscreener.comUCB : Strong first six months – UCB with continued delivery and strong resilience - Marketscreener.comJune 25, 2022 | gurufocus.comAdamis Appoints Vickie Reed to Board of Directors - GuruFocus.comJune 24, 2022 | marketscreener.comUCB : updates financial guidance for 2022 while maintaining 2025 financial guidance - Marketscreener.comJune 8, 2022 | businesswire.comADARx Pharmaceuticals Expands Leadership Team, Appointing Andrew Seacat as Head of Toxicology - Business WireJune 8, 2022 | seekingalpha.comUCB's therapy gets FDA orphan drug status to treat seizures linked with rare epilepsy - Seeking AlphaJune 7, 2022 | streetinsider.comADARx Pharmaceuticals Expands Leadership Team, Appointing Andrew Seacat as Head of Toxicology - StreetInsider.comMay 27, 2022 | streetinsider.comAdamis Appoints Vickie Reed to Board of Directors - StreetInsider.comMay 6, 2022 | markets.businessinsider.comSuneva Medical Inc. Announces Multiple Regulatory Approvals in the U.S. and CanadaApril 19, 2022 | law360.comNorton Rose Adds Brussels Antitrust Pro From Covington - Law360March 28, 2022 | marketscreener.comU.S. FDA approves UCB's drug for rare childhood epilepsy - Marketscreener.comMarch 28, 2022 | reuters.comU.S. FDA approves UCB's drug for rare childhood epilepsy - Reuters.comMarch 7, 2022 | streetinsider.comForm POS AM ZOGENIX, INC. - StreetInsider.comMarch 7, 2022 | seekingalpha.comUCB completes $1.9B acquisition of Zogenix - Seeking AlphaMarch 7, 2022 | benzinga.comUCB Completes Acquisition of Zogenix, Inc. - Benzinga - BenzingaMarch 7, 2022 | prnewswire.comUCB Completes Acquisition of Zogenix, Inc. - PR NewswireMarch 7, 2022 | finance.yahoo.comUCB Completes Acquisition of Zogenix, Inc.March 7, 2022 | marketscreener.comZogenix : Amendment to Annual Report (Form 10-K/A) - Marketscreener.comMarch 7, 2022 | marketbeat.comTrading was temporarily halted for "ZGNX" at 07:03 PM with a stated reason of "News pending."March 6, 2022 | finance.yahoo.comZogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022 - Yahoo FinanceMarch 4, 2022 | benzinga.comZogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN - BenzingaMarch 4, 2022 | streetinsider.comZogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022 - StreetInsider.comMarch 4, 2022 | benzinga.comZogenix To Present New Long-term Data On FINTEPLA (fenfluramine) In Lennox-Gastaut Syndrome (LGS) At AAN 2022 From April 2-7 - BenzingaMarch 4, 2022 | globenewswire.comZogenix To Present New Long-term Data on FINTEPLA® - GlobeNewswireMarch 4, 2022 | finance.yahoo.comZogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022March 2, 2022 | finance.yahoo.comZogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results - Yahoo FinanceMarch 1, 2022 | marketscreener.comZOGENIX, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION (form 10-K) - Marketscreener.comMarch 1, 2022 | marketscreener.comUCB Announces Extension of Tender Offer to Acquire Zogenix, Inc. - marketscreener.comMarch 1, 2022 | globenewswire.comZogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results - GlobeNewswireFebruary 28, 2022 | benzinga.comRecap: Zogenix Q4 Earnings - BenzingaFebruary 28, 2022 | finance.yahoo.comZogenix (ZGNX) Reports Q4 Loss, Tops Revenue Estimates Get Zogenix News Delivered to You Automatically Sign up to receive the latest news and ratings for ZGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Must-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… ZGNX Media Mentions By Week ZGNX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZGNX News Sentiment▼0.200.44▲Average Medical News Sentiment ZGNX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZGNX Articles This Week▼00▲ZGNX Articles Average Week Get Zogenix News Delivered to You Automatically Sign up to receive the latest news and ratings for ZGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SUPN News PCRX News STOK News ORIC News NKTX News BTAI News XENE News PTCT News CORT News PRGO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZGNX) was last updated on 5/23/2024 by MarketBeat.com Staff From Our PartnersTruth about Trump you’ve never heardPorter & CompanyThis could mean the end of the U.S dollar…Colonial MetalsThe 1,000X Crypto PlaybookTrue Market InsidersGold Set to EXPLODE!Gold Safe Exchange[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading AcademyAlex’s “Next Magnificent Seven” stocksThe Oxford ClubNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zogenix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
